Blancato J N
Environmental Monitoring Systems Laboratory, US Environmental Protection Agency, Las Vegas, Nevada 89193.
Environ Health Perspect. 1994 Nov;102 Suppl 9(Suppl 9):133-7. doi: 10.1289/ehp.94102s9133.
Chemical mixtures and multiple routes of exposure are frequently difficult problems for exposure and risk assessors. Chemicals can interact synergistically or antagonistically at a variety of physiologic and biochemical loci within target cells. Many of these interactions can be accounted for with a thorough understanding of the pharmacokinetics of the compounds in the mixture. Many pharmacokinetic processes such as metabolism and absorption can be impacted by the presence of other chemicals in the environment and diet and as a result of medication. In addition, variations between responses as a result of different exposure scenarios (route of exposure, frequency, magnitude) can sometimes result from the impacts upon the pharmacokinetics. Pharmacokinetic models, when properly formulated and tested, can be useful tools to describe and predict the magnitude of the impact of multichemical and multiroute exposures. Several examples will be used to demonstrate this potentially powerful tool and how it can impact the risk assessment process.
化学混合物和多种暴露途径对于暴露和风险评估人员来说常常是难题。化学物质可在靶细胞内的多种生理和生化位点发生协同或拮抗相互作用。通过全面了解混合物中化合物的药代动力学,许多此类相互作用都可以得到解释。许多药代动力学过程,如代谢和吸收,可能会受到环境、饮食中的其他化学物质以及药物的影响。此外,不同暴露场景(暴露途径、频率、剂量)导致的反应差异,有时可能是由于对药代动力学的影响所致。当药代动力学模型得到恰当构建和验证时,它们可以成为描述和预测多化学物质和多途径暴露影响程度的有用工具。将通过几个例子来展示这个潜在的强大工具及其如何影响风险评估过程。